These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22561434)

  • 21. Proinflammatory cytokines as serum biomarker in oral carcinoma-A prospective multi-biomarker approach.
    Schiegnitz E; Kämmerer PW; Schön H; Blatt S; Berres M; Sagheb K; Al-Nawas B
    J Oral Pathol Med; 2018 Mar; 47(3):268-274. PubMed ID: 29272054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of the serum HER-2/neu and squamous cell carcinoma-related antigen expression in patients with oral squamous cell carcinoma.
    Chen CH; Tsai TL; Yang YS; Tsai CC
    J Oral Pathol Med; 2007 Feb; 36(2):83-7. PubMed ID: 17238969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The roles of soluble MICA in immune escape of breast tumor].
    Ye YB; Zhou ZF; Chen Q; Li JY; Chen X; Huang WW
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):904-7. PubMed ID: 18782524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of preoperative squamous cell carcinoma antigen in oral-cavity squamous cell carcinoma.
    Lin WH; Chen IH; Wei FC; Huang JJ; Kang CJ; Hsieh LL; Wang HM; Huang SF
    Laryngoscope; 2011 May; 121(5):971-7. PubMed ID: 21520110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia.
    Nückel H; Switala M; Sellmann L; Horn PA; Dürig J; Dührsen U; Küppers R; Grosse-Wilde H; Rebmann V
    Leukemia; 2010 Jun; 24(6):1152-9. PubMed ID: 20428196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in primary oral squamous cell carcinoma and corresponding metastases in cervical lymph nodes: association with the metastasis suppressor CD82.
    Kawasaki G; Yoshitomi I; Yanamoto S; Yamada S; Mizuno A; Umeda M
    Anticancer Res; 2011 Oct; 31(10):3521-6. PubMed ID: 21965773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between soluble MICA and the MICA A5.1 homozygous genotype in patients with oral squamous cell carcinoma.
    Tamaki S; Kawakami M; Yamanaka Y; Shimomura H; Imai Y; Ishida J; Yamamoto K; Ishitani A; Hatake K; Kirita T
    Clin Immunol; 2009 Mar; 130(3):331-7. PubMed ID: 18951065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematogenous cytokeratin 20 mRNA detection has prognostic impact in oral squamous cell carcinoma: preliminary results.
    Toyoshima T; Vairaktaris E; Nkenke E; Schlegel KA; Neukam FW; Ries J
    Anticancer Res; 2009 Jan; 29(1):291-7. PubMed ID: 19331164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Investigation of CXCR4 in oral squamous cell carcinoma and its influence on proliferation of tumor cells in vitro].
    Xu M; Li WY; Chen XM; Wang XH; Huang J; Wang L
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jun; 41(6):372-5. PubMed ID: 16836911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolism.
    Holdenrieder S; Eichhorn P; Beuers U; Samtleben W; Stieber P; Nagel D; Peterfi A; Steinle A; Salih HR
    Anticancer Res; 2007; 27(4A):2041-5. PubMed ID: 17649819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
    Paschen A; Sucker A; Hill B; Moll I; Zapatka M; Nguyen XD; Sim GC; Gutmann I; Hassel J; Becker JC; Steinle A; Schadendorf D; Ugurel S
    Clin Cancer Res; 2009 Aug; 15(16):5208-15. PubMed ID: 19671853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The soluble major histocompatibility complex class I-related chain A protein reduced NKG2D expression on natural killer and T cells from patients with prolactinoma and non-secreting pituitary adenoma.
    Ma L; Li G; Su Y; He Q; Zhang C; Zhang J
    J Clin Neurosci; 2010 Feb; 17(2):241-7. PubMed ID: 20045334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum circulating human mRNA profiling and its utility for oral cancer detection.
    Li Y; Elashoff D; Oh M; Sinha U; St John MA; Zhou X; Abemayor E; Wong DT
    J Clin Oncol; 2006 Apr; 24(11):1754-60. PubMed ID: 16505414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of serum leptin in oral squamous cell carcinoma.
    Gharote HP; Mody RN
    J Oral Pathol Med; 2010 Jan; 39(1):69-73. PubMed ID: 19817969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense.
    Silva TA; Ribeiro FL; Oliveira-Neto HH; Watanabe S; Alencar Rde C; Fukada SY; Cunha FQ; Leles CR; Mendonça EF; Batista AC
    Oncol Rep; 2007 Nov; 18(5):1107-13. PubMed ID: 17914560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum lipid profile in oral squamous cell carcinoma: alterations and association with some clinicopathological parameters and tobacco use.
    Acharya S; Rai P; Hallikeri K; Anehosur V; Kale J
    Int J Oral Maxillofac Surg; 2016 Jun; 45(6):713-20. PubMed ID: 26899131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling.
    Chang KP; Chang YT; Liao CT; Yen TC; Chen IH; Chang YL; Liu YL; Chang YS; Yu JS; Wu CC
    Clin Chim Acta; 2011 May; 412(11-12):980-7. PubMed ID: 21315702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.
    Rebmann V; Schütt P; Brandhorst D; Opalka B; Moritz T; Nowrousian MR; Grosse-Wilde H
    Clin Immunol; 2007 Apr; 123(1):114-20. PubMed ID: 17218152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The correlation between neck lymphy node metastasis and matrixmetalloproteinase-2 expression at the invasive tumor front of oral squamous cell carcinomas].
    Liu LK; Li YN; Jiang HB; He ZX; Yi XZ
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):106-8. PubMed ID: 15190788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor (VEGF) in sera of oral and oropharyngeal squamous cell carcinoma patients.
    Friedrich RE; Klapdor R; Hagel C; Bartel-Friedrich S
    Anticancer Res; 2010 May; 30(5):1765-6. PubMed ID: 20592375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.